Trade Names:
Synonyms:
Status: Approved (2009)
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: L04AB06
UNII: 91X1KLU43E

Pharmacology

Action Mechanism of Action Reference
INHIBITOR TNF-alpha inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Psoriatic 4 D015535 ClinicalTrials
Arthritis, Juvenile 3 D001171 ClinicalTrials
Spondylarthropathies 3 D025242 ClinicalTrials
Osteoarthritis 3 D010003 ClinicalTrials
Diabetes Mellitus, Type 1 2 D003922 ClinicalTrials
Sarcoidosis 2 D012507 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Labyrinth Diseases 1 D007759 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Infections and infestations
15.39
General disorders and administration site conditions
10.63
Respiratory, thoracic and mediastinal disorders
9.88
Injury, poisoning and procedural complications
9.33
Musculoskeletal and connective tissue disorders
7.04
Gastrointestinal disorders
6.32
Skin and subcutaneous tissue disorders
5.64
Nervous system disorders
4.41
Vascular disorders
4.08
Immune system disorders
4.07
Product issues
3.52
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.82
Renal and urinary disorders
2.46
Cardiac disorders
2.4
Surgical and medical procedures
2.26

Cross References

Resources Reference
CAS NUMBER 476181-74-5
ChEMBL CHEMBL1201833
FDA SRS 91X1KLU43E
Guide to Pharmacology 6776